Interim analysis of a phase 1 study of the antibody-drug conjugate SGN-CD19A in relapsed or refractory B-lineage acute leukemia and highly aggressive lymphoma Meeting Abstract


Authors: Fathi, A. T.; Chen, R.; Trippett, T. M.; O'Brien, M. M.; DeAngelo, D. J.; Shah, B. D.; Cooper, T. M.; Foran, J. M.; Hale, G. A.; Pressey, J.; Silverman, L. B.; Tibes, R.; Kim, S.; Albertson, T. M.; Sandalic, L.; Zhao, B. T.; Borate, U.
Abstract Title: Interim analysis of a phase 1 study of the antibody-drug conjugate SGN-CD19A in relapsed or refractory B-lineage acute leukemia and highly aggressive lymphoma
Meeting Title: 56th Annual Meeting of the American Society of Hematology (ASH)
Journal Title: Blood
Volume: 124
Issue: 21
Meeting Dates: 2014 Dec 6-9
Meeting Location: San Francisco, CA
ISSN: 0006-4971
Publisher: American Society of Hematology  
Date Published: 2014-12-06
Language: English
ACCESSION: WOS:000349242700139
PROVIDER: wos
DOI: 10.1182/blood.V124.21.963.963
Notes: Meeting Abstract: 963 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Tanya M Trippett
    126 Trippett